-
641
-
642
-
643
Ketamine Infusion as an Adjunct to Opioid Analgesia in Pediatric Patients with High-Risk Neuroblastoma Undergoing Treatment with Dinutuximab: Adverse Effects and Safety in a Non-IC...
Published 2025-01-01“…No other significant statistical differences in adverse effects were observed in patients’ receiving opioids versus opioids plus ketamine.Conclusion: Findings suggest ketamine is safe in a non-ICU setting for treatment of complex pain during anti-GD2 immunotherapy. Additional prospective studies are needed to quantify the effect of reducing opioid side effects by including ketamine in pain management plans.Keywords: anti-GD2 immunotherapy, dinutuximab, neuropathic pain, pediatric analgesia, ketamine, high-risk neuroblastoma, opioid…”
Get full text
Article -
644
Supervised Injecting Room Cohort Study (SIRX): study protocol
Published 2025-02-01Get full text
Article -
645
-
646
-
647
-
648
-
649
-
650
-
651
-
652
-
653
-
654
-
655
-
656
-
657
-
658
-
659
COVID-19 in discharged patients with diabetes and chronic kidney disease: one-year follow-up and evaluation
Published 2025-02-01Get full text
Article -
660